These studies indicate that desmoplasia, a feature of the microenvironment of many tumors, can alter the repertoire of PRL-initiated signals to favor pro-tumor pathways and anti-estrogen resistance, thus illuminating one mechanism underlying the apparent disparate reports of the outcomes of PRL signals in ER+ breast cancers. This evidence concerns the gene PRL and breast cancer.